MedPath

Microarray Analysis of microRNA Expression in Basal Cell Carcinoma

Completed
Conditions
Basal Cell Carcinoma
Registration Number
NCT01498250
Lead Sponsor
Ruhr University of Bochum
Brief Summary

Perturbations in microRNA (miRNA) expression profiles has been reported for a variety of cancers. This study will be an exploratory analysis of miRNA expression in basal cell carcinoma by miRNA expression profiling using microarrays.

Detailed Description

Perturbations in the expression profiles of microRNAs (miRNAs) have been reported for a variety of different cancers. Basal cell carcinoma (BCC) of the skin has not been systematically evaluated regarding differentially expressed miRNAs. Patients with BCC are included in the study to perform an exploratory analysis by miRNA expression profiling using microarrays. Expression levels of miRNA candidates will be validated by TaqMan real-time quantitative polymerase chain reaction (RT-PCR).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
7
Inclusion Criteria
  • Basal Cell Carcinoma
Exclusion Criteria
  • Other Skin Cancer than Basal Cell Carcinoma

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum

🇩🇪

Bochum, NRW, Germany

© Copyright 2025. All Rights Reserved by MedPath